| SAN DIEGO, Apr 07, 2009 (BUSINESS WIRE) -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company
will release its first quarter 2009 financial results on Thursday, April
30, 2009 at approximately 4:00 p.m. Eastern Time (ET). The announcement
will be followed by a conference call with management at 4:30 p.m. ET.
The conference call will be webcast live and may be accessed on the
investors section of the Company's web site at www.gen-probe.com.
An archived version of the webcast will be available on the same web
site for at least 90 days. A telephone replay will also be available for
24 hours after the call ends. To access the replay, please call
866-454-1437 (US) or 203-369-1239 (international).
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development,
manufacture and marketing of rapid, accurate and cost-effective nucleic
acid tests (NATs) that are used primarily to diagnose human diseases and
screen donated human blood. Gen-Probe has more than 25 years of NAT
expertise, and received the 2004 National Medal of Technology, America's
highest honor for technological innovation, for developing NAT assays
for blood screening. Gen-Probe is headquartered in San Diego and employs
approximately 1,000 people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking
Statements
Any statements in this press release about our expectations, beliefs,
plans, objectives, assumptions or future events or performance are not
historical facts and are forward-looking statements. Forward-looking
statements are not guarantees of performance. They involve known and
unknown risks, uncertainties and assumptions that may cause actual
results, levels of activity, performance or achievements to differ
materially from those expressed or implied by any forward-looking
statement. For information about risks and uncertainties we face and a
discussion of our financial statements and footnotes, see documents we
have filed with the SEC, including the Form 10-K for the year ended
December 31, 2008, and all subsequent periodic filings made with the
SEC. We assume no obligation and expressly disclaim any duty to update
any forward-looking statement to reflect events or circumstances after
the date of this press release or to reflect the occurrence of
unanticipated events.
SOURCE: Gen-Probe Incorporated
Gen-Probe Incorporated
Paula Izidoro
Investor Relations
858-410-8904
paulai@gen-probe.com
|
